AU2002367323A1 - Benzothieno (3,2- - Google Patents

Benzothieno (3,2-

Info

Publication number: AU2002367323A1
Authority: AU; Australia
Prior art keywords: benzothieno
Prior art date: 2001-12-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002367323A

Other versions

AU2002367323A8 (en

Inventor

Soongyou Choi

Gaetan H. Ladouceur

Yamin Wang

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer Pharmaceuticals Corp

Original Assignee

Bayer AG

Bayer Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-28

Filing date

2002-12-28

Publication date

2003-07-24

2002-12-28 Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG

2003-07-24 Publication of AU2002367323A1 publication Critical patent/AU2002367323A1/en

2011-08-25 Publication of AU2002367323A8 publication Critical patent/AU2002367323A8/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

AU2002367323A 2001-12-28 2002-12-28 Benzothieno (3,2- Abandoned AU2002367323A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US34415101P	2001-12-28	2001-12-28
US60/344,151		2001-12-28
PCT/US2002/041859 WO2003057161A2 (en)	2001-12-28	2002-12-28	BENZOTHIENO [3,2-c]PYRAZOLYL AND BENZOFURANO [3,2-c] PYRAZOLYL COMPOUNDS, THEIR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR AND INTERMEDIATE COMPOUNDS THEREOF

Publications (2)

Publication Number	Publication Date
AU2002367323A1 true AU2002367323A1 (en)	2003-07-24
AU2002367323A8 AU2002367323A8 (en)	2011-08-25

Family

ID=23349272

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002367323A Abandoned AU2002367323A1 (en)	2001-12-28	2002-12-28	Benzothieno (3,2-

Country Status (2)

Country	Link
AU (1)	AU2002367323A1 (en)
WO (1)	WO2003057161A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CL2004000826A1 (en)	2003-04-25	2005-03-04	Pfizer	USE OF AN AGONIST FOR THE 5-HT2C RECEPTOR TO PREPARE A USEFUL MEDICINAL PRODUCT IN THE TREATMENT OF URINARY INCONTINENCE CAUSED BY STRESS, WITH THE CONDITION THAT THE AGONIST IS NOT 1- [6-CHLORINE-5- (TRIFLUOROMETIL) -2- PIRIDINIL] PIPERAZINA (ORG-129
EP1734963A4 (en)	2004-04-02	2008-06-18	Merck & Co Inc	METHOD FOR TREATING MEN WITH METABOLIC AND ANTHROPOMETRIC DISORDERS
US8685924B2 (en)	2004-08-25	2014-04-01	Takeda Pharmaceutical Company Limited	Preventives/remedies for stress urinary incontinence and method of screening the same
AU2012201515B2 (en) *	2004-12-23	2015-01-29	Arena Pharmaceuticals, Inc.	5HT2C receptor modulator compositions and methods of use
AU2005322183B2 (en) *	2004-12-23	2012-03-29	Arena Pharmaceuticals, Inc.	5HT2C receptor modulator compositions and methods of use
EP2018863B9 (en)	2006-05-16	2015-02-18	Takeda Pharmaceutical Company Limited	Fused heterocyclic compound and use thereof
ES2745411T3 (en)	2006-07-27	2020-03-02	Wang Nai Fang	Arylsulfanil compounds and compositions for administration of active agents
JP5520051B2 (en)	2007-11-15	2014-06-11	武田薬品工業株式会社	Condensed pyridine derivatives and uses thereof
EP2288585A1 (en)	2008-03-04	2011-03-02	Arena Pharmaceuticals, Inc.	Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
CN102648170A (en)	2009-06-18	2012-08-22	艾尼纳制药公司	Processes for the preparation of 5-HT2C receptor agonists
WO2011071136A1 (en)	2009-12-11	2011-06-16	アステラス製薬株式会社	Therapeutic agent for fibromyalgia
US9045431B2 (en)	2010-06-02	2015-06-02	Arena Pharmaceuticals, Inc.	Processes for the preparation of 5-HT2C receptor agonists
EP2611782A1 (en)	2010-09-01	2013-07-10	Arena Pharmaceuticals, Inc.	Salts of lorcaserin with optically active acids
CN103347523A (en)	2010-09-01	2013-10-09	艾尼纳制药公司	Administration of lorcaserin to individual with renal impairment
KR20130101524A (en)	2010-09-01	2013-09-13	아레나 파마슈티칼스, 인크.	Non-hygroscopic Salts of 5-HT2C Agonists
CN103189053A (en)	2010-09-01	2013-07-03	艾尼纳制药公司	Modified release dosage form of a 5-HT2C agonist for weight management
CA2886875A1 (en)	2012-10-09	2014-04-17	Arena Pharmaceuticals, Inc.	Method of weight management
GB201304811D0 (en) *	2013-03-15	2013-05-01	Proximagen Ltd	Novel treatment for hypertension
WO2019131902A1 (en)	2017-12-27	2019-07-04	武田薬品工業株式会社	Therapeutic agent for stress urinary incontinence and fecal incontinence

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW403738B (en) *	1994-08-12	2000-09-01	Hoffmann La Roche	Tricyclic pyrazole derivatives

2002
- 2002-12-28 WO PCT/US2002/041859 patent/WO2003057161A2/en not_active Ceased
- 2002-12-28 AU AU2002367323A patent/AU2002367323A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2002367323A8 (en)	2011-08-25
WO2003057161A3 (en)	2011-08-04
WO2003057161A2 (en)	2003-07-17

Publication	Publication Date	Title
AU2002360508A1 (en)	2003-06-23	Substituted hydroxyethylamines
AU2002313565A1 (en)	2003-03-18	Putter-heads
AU2002367323A1 (en)	2003-07-24	Benzothieno (3,2-
AU2002251024A1 (en)	2003-03-20	Substituted fluoroalcoxyphenylsulfonylurea
AU2002343312A1 (en)	2003-06-10	Two fixed-beams tx-diversity
AU2002321215A1 (en)	2003-05-22	Substituted 4-aminocyclohexanols
AU2002319532A1 (en)	2003-02-24	Feeding-bottles
AU2002313943A1 (en)	2003-02-24	Electromobile
AU2002226571A1 (en)	2002-08-12	Biligands
AU2001100406A4 (en)	2001-11-01	DriverSMS
AU2002361027A1 (en)	2003-06-30	Substituted 1,5-diaminopentan-3-ol compounds
AU2002313073A1 (en)	2002-12-03	Phytocystatin
AUPR518501A0 (en)	2001-06-14	Yin yang-1
AU2002257925A1 (en)	2003-06-30	Numberplates
AU2001100214A4 (en)	2001-08-30	Dolly-trolley
AU2001100532A4 (en)	2001-11-29	FonePark
AU2001100522A4 (en)	2001-11-22	e-Trans
AU2001100338A4 (en)	2001-10-04	Sunglove
AU2002100746A4 (en)	2003-05-29	Adrail
AU2002341165A1 (en)	2003-05-12	1,5-anhydro-d-fructose dehydratase
AU2002358003A1 (en)	2003-06-10	Substituted acylaminophenyluracils
AU2002317861A1 (en)	2003-01-29	Substituted benzo-nitro-heterocycles
AUPR788401A0 (en)	2001-10-18	Fusball (sport)
AUPR383801A0 (en)	2001-04-12	Increased superannuation
AUPR237701A0 (en)	2001-02-01	La sachee

Legal Events

Date	Code	Title	Description
2004-09-23	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase